ELIXIR MYEXO product carton
MYEXO

AUTOLOGOUS EXOSOMES

Autologous exosomes for wound care — chronic and post-surgical wounds.

Autologous exosomes for wound care — chronic and post-surgical wounds.

Physician controlledExosome-rich plasmaPatient-derived & safeClosed systemCE certified · ISO 13485:2016

النسخة العربية ←

12TExosomes in 10 mL
30 minClosed-system preparation
≥89%Recovery
120 nmAverage exosome size (±15)
MyExo for wound care

Autologous exosomes for chronic & post-surgical wounds

Wound healing is one of the clinical fields where autologous exosome-rich plasma is applied. In chronic or post-surgical wounds, exosomes stimulate fibroblast proliferation, endothelial sprouting and keratinocyte migration. Their anti-inflammatory action helps re-establish balance in non-healing wounds.

wound care
Mechanism

Four mechanisms working together

01

Cellular Communication

Regulatory RNAs and proteins support cell survival, proliferation and differentiation, and promote neovascularisation in endothelial cells.

02

Growth-Factor Cooperation

PDGF, VEGF, TGF-β and IGF-1 attract cells to the injury site, stimulate matrix deposition and improve vascular supply.

03

Inflammation Resolution

Macrophage polarisation shifts away from IL-1β and TNF-α toward IL-10 and TGF-β.

04

Structural Remodelling

A temporary fibrin–exosome scaffold supports organised, vascularised tissue rather than fibrotic scar.

What the research says

Laboratory and animal research

Diabetic wound model (Cao et al., iScience, 2023): exosomes from PRP carried PDGF-BB, VEGF and bFGF. In high-glucose conditions they protected skin fibroblasts, restored their growth and migration, and in diabetic rats increased collagen deposition, new blood vessel formation and wound closure, via the PDGF-BB/JAK2/STAT3 pathway.

Activation method (Rui et al., Cell Transplantation, 2021): the way platelets are activated changed both the number of exosomes released and their growth-factor content, and the growth factors were found mainly inside the exosomes.

These are pre-clinical studies in cells and animals, with laboratory-isolated exosomes rather than MyExo. Clinical decisions remain with the treating physician.

Cao W, et al. iScience. 2023;26:108236. doi:10.1016/j.isci.2023.108236 · Rui S, et al. Cell Transplant. 2021;30:1–13. doi:10.1177/09636897211017833

MyExo at a glance

Why autologous matters

12 trillionexosomes in 10 mL of final product
30 minfrom blood draw to exosome-rich plasma
Donor-free

From the Patient's Own Blood

Donor-free, with no additives.

Fresh

Prepared at the Point of Care

Physician-prepared, fresh, in the clinic.

Human EVs

Not a Cosmetic "Exosome"

Unlike cosmetic or plant-derived "exosome" products, which are typically topical and not interchangeable with human extracellular vesicles.

For healthcare professionals. Product information provided by the manufacturer. Distributed by Bionics Medical in the UAE and Saudi Arabia.

Scroll to Top